TrialNature cancer2026

Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial.

Kimberly J Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.